Israeli startup CytoReason raises $80M to expand AI model, open hub in Massachusetts
Israeli startup CytoReason, maker of a computation model to map and compare treatments, announced it secured $80 million in funding. Pfizer, OurCrowd, NVIDIA and Thermo Fisher…











